CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design

MLA

David Schiff, et al. CODEL: Phase III Study of RT, RT + TMZ, or TMZ for Newly Diagnosed 1p/19q Codeleted Oligodendroglioma. Analysis from the Initial Study Design. Mar. 2021. EBSCOhost, https://doi.org/10.1093/neuonc/noaa168.

APA

David Schiff, Kurt A. Jaeckle, Evanthia Galanis, Kenneth Aldape, Donald Nordstrom, Stuart A. Grossman, Jeffrey S. Wefel, J. Gregory Cairncross, Michael A. Vogelbaum, Karla V. Ballman, F. Dhermain, Michael Weller, Martin Klein, Patrick J. Flynn, Wolfgang Wick, Paul D. Brown, S. Keith Anderson, Robert B. Jenkins, Caterina Giannini, … Jane H. Cerhan. (2021). CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design. https://doi.org/10.1093/neuonc/noaa168

Chicago

David Schiff, Kurt A. Jaeckle, Evanthia Galanis, Kenneth Aldape, Donald Nordstrom, Stuart A. Grossman, Jeffrey S. Wefel, et al. 2021. “CODEL: Phase III Study of RT, RT + TMZ, or TMZ for Newly Diagnosed 1p/19q Codeleted Oligodendroglioma. Analysis from the Initial Study Design,” March. doi:10.1093/neuonc/noaa168.